Clinical Trial Update: A Study of the Concurrent Use of AGN-190584 and AGN-199201 in Participants With Presbyopia [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating concurrent use of AGN-190584 and AGN-199201 in presbyopia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Presbyopia

Drugs mentioned

• AGN-190584
• AGN-199201

Snippet

Sponsor: Allergan | Conditions: Presbyopia | Phase 2 | Status: COMPLETED | Results posted: 2020-12-22